Drug
Biothrax
Biothrax: highest development phase Phase 3, developed by Emergent BioSolutions. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| BioThrax NCT01491607 | Phase 3 | Anthrax |
| BioThrax NCT01753115 | Phase 2 | Anthrax |
| BioThrax NCT01263691 | Phase 1 | Bacillus Anthracis (Anthrax) Infection |
Latest
Follow Biothrax on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.